Education
About Us
Working with TipRanks
Follow Us
Corvus Pharmaceuticals Inc (CRVS)
NASDAQ:CRVS
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ -151.00K | $ -367.00K | $ -460.00K | $ -632.00K |
| Operating Income | $ -27.55M | $ -23.41M | $ -32.56M | $ -38.63M | $ -43.76M |
| EBITDA | $ -27.55M | $ -26.88M | $ -40.94M | $ -42.78M | $ -5.36M |
| Net Income | $ -62.29M | $ -27.03M | $ -50.05M | $ -38.20M | $ -4.82M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 51.96M | $ 27.15M | $ 42.30M | $ 69.45M | $ 44.26M |
| Total Assets | $ 68.91M | $ 45.55M | $ 68.24M | $ 109.45M | $ 85.53M |
| Total Debt | $ 1.12M | $ 1.37M | $ 2.60M | $ 3.65M | $ 2.31M |
| Net Debt | $ -7.62M | $ -11.25M | $ -10.56M | $ -59.81M | $ -14.14M |
| Total Liabilities | $ 36.34M | $ 6.87M | $ 12.13M | $ 12.29M | $ 13.38M |
| Stockholders' Equity | $ 32.57M | $ 38.68M | $ 56.12M | $ 97.16M | $ 72.15M |
| Cash Flow | |||||
| Free Cash Flow | $ -25.42M | $ -23.97M | $ -27.29M | $ -36.72M | $ -34.85M |
| Operating Cash Flow | $ -25.42M | $ -23.93M | $ -27.02M | $ -36.72M | $ -34.78M |
| Investing Cash Flow | $ -27.48M | $ 15.54M | $ -23.28M | $ 21.56M | $ 44.77M |
| Financing Cash Flow | $ 49.03M | $ 7.86M | $ 0.00 | $ 62.16M | $ 1.31M |